Logan Reed
Whooping cough, or pertussis, is a highly infectious and serious illness that can be fatal for young babies. Vaccinating pregnant women against whooping cough has been shown to be highly effective in protecting their babies until they can receive their own vaccinations. The immunity from the vaccine passes through the placenta to the unborn baby, offering protection until they are old enough to be routinely vaccinated at around two months old. The CDC and other health authorities recommend that pregnant women get the Tdap vaccine, which is safe for both mother and baby, during the third trimester of pregnancy, ideally between 27 and 36 weeks.
| Characteristics | Values |
|---|---|
| Who should get the vaccine | Pregnant women |
| When to get the vaccine | Between 16 and 32 weeks of pregnancy, preferably in the earlier part of this period |
| How often to get the vaccine | Once during each pregnancy |
| Type of vaccine | Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine) |
| Safety | Safe for pregnant women and their babies with mild or moderate side effects |
| Effectiveness | Provides protection for mothers and babies |
| Protection duration | Babies are protected until they are vaccinated at 2 months old |
Explore related products
What You'll Learn
Whooping cough vaccine is safe during pregnancy
Whooping cough, or pertussis, is a highly infectious and serious illness that can be life-threatening for young babies. It can lead to pneumonia and brain damage, and most babies with whooping cough require hospital treatment. The illness is highly dangerous for babies who are too young to start their vaccinations.
The whooping cough vaccine is safe for pregnant women and their babies. The Tdap vaccine does not contain thimerosal, and there is no evidence that it increases the risk of pregnancy complications. The CDC and FDA monitor vaccine safety through the Vaccine Adverse Event Reporting System (VAERS), which has not found any safety concerns for pregnant women or their babies. The Food and Drug Administration (FDA) has approved the Tdap vaccines Boostrix® and Adacel® for use during pregnancy.
Multiple studies have shown that vaccinating pregnant women helps protect their babies from developing whooping cough in the first few weeks of their lives. The immunity passed on by the mother through the placenta provides passive protection for the baby until they can receive their own vaccinations. The CDC and various medical associations dedicated to the health of pregnant women and children recommend the Tdap vaccine during pregnancy.
The optimal time to get the vaccine is between 27 and 36 weeks of gestation, preferably in the earlier part of this period. It is recommended that pregnant women receive the Tdap vaccine during each pregnancy, ideally during the third trimester, to ensure the greatest number of protective antibodies are passed on to the infant. While the vaccine can be administered at any point during pregnancy, it should not be repeated between 27 and 36 weeks if administered earlier.
Pregnant women can receive the Tdap vaccine from their GP or at an antenatal clinic, ideally at around 20 weeks of pregnancy.
Vaccine Scarring: The 60s Legacy
You may want to see also
Explore related products
The optimal time to get the vaccine is between 27-36 weeks
The whooping cough vaccine is safe for pregnant women and their babies. It is recommended that pregnant women get vaccinated to protect their babies from developing whooping cough in their first few weeks of life. The immunity that the mother gains from the vaccine passes through the placenta to the unborn baby. This will help protect the baby until they can receive their own vaccinations at eight weeks old.
The optimal time to get the vaccine is between 27 and 36 weeks. This is because the protective antibodies against whooping cough peak about two weeks after vaccination. It takes time for these antibodies to pass to the baby, and their amount in the mother's body decreases over time. Hence, getting vaccinated between 27 and 36 weeks ensures the baby receives the greatest number of protective antibodies and the best protection possible. Getting vaccinated within this period lowers the risk of whooping cough in babies younger than two months old by 78%.
If you are pregnant and have not received the vaccine by 32 weeks, you can still get vaccinated later, even after giving birth. However, this is not ideal, as your baby is less likely to get protection from you. At this stage, the vaccination may not directly protect your baby, but it will help protect you from whooping cough and from passing it on to your baby.
The whooping cough vaccine is not a "live" vaccine, meaning it cannot cause whooping cough. It is a combined vaccine that protects against different diseases, including tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis. It is safe for both mother and baby, and there is no evidence of any risk to the baby if the mother is breastfeeding.
Topical Vaccines: A New Way to Immunize?
You may want to see also
Explore related products
Getting vaccinated protects both mother and baby
Getting vaccinated against whooping cough during pregnancy is highly recommended by healthcare professionals. It is a safe and effective way to protect both the mother and her unborn child.
Whooping cough, or pertussis, is a highly infectious and serious illness that can lead to severe complications, especially in young babies. It causes coughing and choking, making it hard to breathe, and often requires hospitalisation. In severe cases, it can lead to pneumonia, brain damage, and even death. Babies are at the greatest risk of contracting pertussis in their first few months of life, before they have received their own vaccinations.
The whooping cough vaccine, or Tdap, has been routinely offered to pregnant women in the UK since 2012, and its safety has been carefully monitored. Multiple studies and safety systems have found no evidence of risks or harm to pregnant women or their babies. The vaccine is not a "live" vaccine, meaning it cannot cause whooping cough. The most common side effects are mild and typically include redness, swelling, or tenderness at the injection site, and these side effects are self-resolving.
When a pregnant woman receives the Tdap vaccine, her body creates protective antibodies that are passed on to the baby through the placenta. These antibodies provide short-term protection for the baby, helping to prevent them from developing whooping cough in their first few weeks of life. The optimal time to receive the vaccine is between 27 and 36 weeks of gestation, preferably earlier in this period, to allow for the greatest transfer of antibodies to the infant.
By getting vaccinated during pregnancy, mothers can help protect their babies from the serious complications of whooping cough until they are old enough to receive their own vaccinations. This proactive step ensures that both mother and baby have a strong defence against whooping cough and reduces the risk of hospitalisation or severe outcomes associated with the disease.
The Hunt for a Lyme Disease Vaccine: Human Trials
You may want to see also
Explore related products
The vaccine is recommended by doctors and midwives
The whooping cough vaccine is recommended by doctors and midwives. It is a safe and effective way to protect both mother and baby from the disease. The vaccine has been used in pregnant women since 2012, and there have been no safety concerns for mothers or their babies. The vaccine does not contain thimerosal and is not a live vaccine, meaning it cannot give you or your baby whooping cough.
The CDC, FDA, and other medical associations dedicated to the health of pregnant women and children support the recommendation of the vaccine during pregnancy. The CDC and FDA monitor vaccine safety through the Vaccine Adverse Event Reporting System (VAERS), which has found no safety issues with the vaccine for pregnant women or their babies. The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK also monitors the safety of vaccines and has found no evidence of risks to pregnancy or babies. Published research from the UK vaccination programme supports this, showing that the vaccine is highly effective in protecting young babies until they can receive their first vaccination.
Doctors and midwives recommend that pregnant women receive the vaccine to provide the best protection for mothers and newborns. Getting vaccinated during pregnancy will not increase the risk of pregnancy complications, and it will help protect your baby from whooping cough in their first few weeks of life. The immunity you gain from the vaccine passes through the placenta to your unborn baby, providing them with protection until they can receive their own vaccinations.
It is recommended that pregnant women receive the vaccine between 27 and 36 weeks of pregnancy, preferably earlier in this period. This timing allows for the greatest number of protective antibodies to be passed on to the infant. While you can receive the vaccine at any point during pregnancy, getting it earlier in the third trimester provides optimal protection for your baby.
California's Vaccine Philosophy: Pre-SB277 Exemptions
You may want to see also
Explore related products
There are mild side effects, but severe reactions are rare
Pregnant women can get vaccinated against whooping cough to help protect their babies. The immunity from the vaccine passes to the baby through the placenta, providing passive protection until the baby can be routinely vaccinated at 8 weeks old.
The Tdap vaccine is very safe for pregnant women and their babies. Most side effects are mild or moderate and self-resolving. Common side effects include a high temperature, irritation at the injection site, nausea, loss of appetite, tiredness, and headaches. These side effects don't affect daily activities and typically get better on their own within a few days.
Severe side effects from the Tdap vaccine are extremely rare, especially in adults. The Vaccine Adverse Event Reporting System (VAERS) and the Food and Drug Administration (FDA) monitor vaccine safety, and neither has found any safety concerns for pregnant women or their babies after Tdap vaccination. The CDC and FDA's safety systems have not identified any safety signals or trends indicating risks associated with Tdap vaccination during pregnancy.
Published research and studies from the UK and England's vaccination programmes support the safety and effectiveness of the whooping cough vaccine for pregnant women. The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK also monitors vaccine safety and found no evidence of risks to pregnancy or babies in a study of 20,000 vaccinated women.
Getting vaccinated during pregnancy is highly recommended to protect both mothers and newborns.
South Africans and the Yellow Fever Vaccine
You may want to see also
Frequently asked questions
Yes, it is safe and highly recommended. The vaccine has been used in the UK since 2012 and there have been no safety concerns for pregnant women or their babies.
The best time to get vaccinated is between 16 and 32 weeks of pregnancy. However, you can get the vaccine at any time during your pregnancy.
Getting vaccinated during pregnancy will help protect your baby from whooping cough in the first few weeks of their life. The immunity you get from the vaccine passes through the placenta to your unborn baby.
